SCHEMBL6804816

SCHEMBL6804816

C[C@H](Cc1ccc(S(=O)(=O)c2c(Cl)cccc2C=O)cc1)NC(=O)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.41
KCNH2 Q12809 1/20 0.41
CNR1 P21554 2/20 0.37
ABCC9 O60706 2/20 0.37
ABCC8 Q09428 2/20 0.37
KCNJ11 Q14654 2/20 0.37
KCNJ8 Q15842 2/20 0.37
GAA P10253 2/20 0.36
ACACB O00763 5/20 0.36
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
NOS2 P35228 1/20 0.34
TAAR1 Q96RJ0 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.33
CAPN1 P07384 1/20 0.33
ITGB1 P05556 1/20 0.33
ITGA4 P13612 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6679761 0.86 ESR1 (0.41) ESR1KCNH2CNR1ABCC9ABCC8
SCHEMBL6682412 0.82 ACACB (0.41) ESR1KCNH2CNR1ABCC9ABCC8
SCHEMBL6809464 0.80 ESR1 (0.42) ESR1KCNH2CNR1ABCC9ABCC8
SCHEMBL6917853 0.80 ESR1 (0.41) ESR1KCNH2ACACBNPC1RAB9A
SCHEMBL6804246 0.78 CNR1 (0.43) ESR1KCNH2CNR1ABCC9ABCC8
SCHEMBL6805279 0.77 CNR1 (0.42) ESR1KCNH2CNR1ABCC9ABCC8
SCHEMBL6805002 0.77 CNR1 (0.40) ESR1KCNH2CNR1GAAACACB
SCHEMBL6810020 0.77 ABCB11 (0.41) ESR1KCNH2CNR1ABCC9ABCC8
SCHEMBL6540648 0.77 ABCB11 (0.41) ESR1KCNH2CNR1ABCC9ABCC8
SCHEMBL6541437 0.77 ESR1 (0.46) ESR1KCNH2CNR1ABCC9ABCC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040106653-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106653-A1 Aminoalcohol derivatives FANCD2, FANCI, HRH2 ESR1 3850/4885KCNH2 184/4885CNR1 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.